| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-12 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |